Trying to raise the profile of pancreatic cancer, deadly yet lagging in research funding
Click to skip ad »
For Charles Yeo and his colleagues, the fight against pancreatic cancer does not begin and end in the operating room. Working with patients ranges from boosting their morale to subtle requests that they become advocates for pancreatic cancer research, which he says has long been underfunded.
»Read story: Trying to raise the profile of pancreatic cancer, deadly yet lagging in research funding
»Read story: Trying to raise the profile of pancreatic cancer, deadly yet lagging in research funding




